DeCure's autonomous Rare AI scientist is researching a drug-repurposing hypothesis for Reis-Bucklers corneal dystrophy — screening already-approved drugs against its 1-gene Open Targets disease module to publish open-access research. Research is fast; the path to publication is funded in milestone stages.
Disease moduleReis-Bucklers corneal dystrophy maps to a 1-gene Open Targets module — the target space DeCure's AI scientist screens approved drugs against.
DeCure.ai methodSignature reversal (LINCS) plus network proximity (STRING) rank already-approved drugs likely to perturb this module — the same engine that produces DeCure.ai's repurposing hypotheses.
Repurposing thesisScreening approved medicines against this disease module, then publishing the evidence for the strongest candidate. Known pharmacology and human exposure data make the first question sharper — they do not establish safety or efficacy in a new indication.
Research record
01
ResearchComing soon
Candidate research + dossier — target rationale, drug-repurposing thesis and evidence pack.proof: Published dossier + on-chain hash
02
ValidationComing soon
In-vitro biological validation at a contract research org (CRO).proof: CRO contract + in-vitro report
03
Peer review & paperComing soon
Peer-reviewed paper published open-access (preprint + journal).proof: DOI + open-access link + on-chain hash
Current lead
No approved-drug candidate for reis-bucklers corneal dystrophy is corroborated in the literature DeepSearch retrieved. Some conditions are managed with non-pharmacological care — a device, surgery or physical therapy — rather than a medicine; that may be the case here, or the literature we found may simply be too sparse yet to support a drug-repurposing angle.
Molecular view
transforming growth factor beta induced (TGFBI) — TGFBI is one of the genes genetically linked to this disease in Open Targets — shown as context, not as a drug target we're pursuing: no approved-drug candidate for this disease is yet corroborated in the literature we found.
Loading structure…
helix sheet apo structuredrag to rotate · scroll to zoom
RCSB Protein Data Bank · entry 5NV6 · 2.93 Å · ligand none (apo structure). Experimental structure, not a prediction.
What the evidence adds up to
In a 1974 study of a single family across five generations, 80% of those with Reis-Bucklers corneal dystrophy had recurrent corneal ulceration in childhood that stopped in the second or third decade. All affected individuals had progressive visual deterioration throughout life. Three patients received penetrating corneal grafts, which gave excellent visual results; lamellar grafting had previously given poor results. The report does not give sample sizes beyond the three graft recipients, nor does it provide survival or response rates.
By 1989, an argument was published that Reis-Bücklers' corneal dystrophy and granular corneal dystrophy Groenouw type I are the same disease. The author compared slitlamp photographs from the literature with photographs from his own patients with granular corneal dystrophy and concluded that most histological and ultrastructural findings described for Reis-Bücklers' are either congruent with granular corneal dystrophy or unspecific. This remains a contested classification, not a settled fact.
In 1999, molecular genetics work established that mutations in a single gene, keratoepithelin, cause several distinct corneal dystrophies affecting the Bowman layer and the stroma, including those previously labelled Reis-Bücklers'. Genetic heterogeneity and phenotypic diversity were noted as common themes. The paper proposed a new classification based on molecular etiology but did not test any treatment.
No drug therapy appears in any of these abstracts. What is still missing is any clinical trial of a pharmacological intervention, any molecular characterisation of the specific keratoepithelin mutation in the 1974 family, and any patient stratification by genotype. Money for drug-repurposing screens in this rare dystrophy has not been reported.
Evidence
Retrieved by DeepSearch across 234,678,978 indexed works and resolved on OpenAlex — ranked by citations, including the results that did not work.
Archives of Ophthalmology · 1974 · 30 citations
Reis-Bucklers Dystrophy
AbstractThe dominant inheritance of a superficial corneal dystrophy was traced through five generations of a family. Eighty percent of those affected had recurrent corneal ulceration during childhood that gradually disappeared in the second and third decades. All of those affected had progressive visual deterioration throughout life. The corneal changes could be seen in seven patients who were photographed on the slitlamp. Previously, Reis-Bücklers dystrophy was often treated by lamellar grafting with poor visual results. Three patients had penetrating corneal grafts that gave excellent visual results.
Current Opinion in Ophthalmology · 1999 · 26 citations
A new clinical perspective of corneal dystrophies through molecular genetics
AbstractIn the past 2 years, significant advances have been made in the genetics of corneal dystrophies. Genetic heterogeneity (one disease condition caused by single mutations in any one of multiple genes) and phenotypic diversity (many disease conditions caused by mutations in a single gene) are common emerging themes. Genetic heterogeneity in Meesmann corneal dystrophy was established with the identification of two causative genes, keratins 3 and 12, that encode cytoskeletal proteins. Conversely, mutations in a single gene, keratoepithelin, were found to cause several distinct corneal dystrophies affecting the Bowman layer and the stroma. We present a novel preliminary classification of corneal dystrophies based on molecular etiology. This classification may be useful in understanding the pathogenesis of corneal dystrophies and in developing new strategies to treat these dystrophies.
Granular corneal dystrophy Groenouw type I (Grl) and Reis‐Bücklers' corneal dystrophy (R‐B) One Entity?
AbstractThis paper maintains that Reis-Bücklers' corneal dystrophy and granular corneal dystrophy Groenouw type I are one and the same disease. Included are some of the technically best photographs of Reis-Bücklers' dystrophy found in the literature, and these are compared with photographs from patients with granular corneal dystrophy examined by the author. It is argued that most of the histological and ultrastructural findings on Reis Bücklers' dystrophy described in the literature are either congruent with what is found in granular corneal dystrophy or unspecific.
Disease module: DeepOracle (Open Targets). Structures: RDKit from PubChem SMILES. Literature: retrieved by DeepSearch across 234,678,978 indexed works (targeted per-candidate search), resolved on OpenAlex.
DeCure is a research and publication project, not medical advice and not a treatment. "DeCure for X" describes a research goal, not a claim that a cure exists. Backing a cure is a contribution to fund the research — it is not an investment, and confers no yield, royalty, equity or IP ownership. Papers are published open-access by the DeCure.ai DAO.
